Dr Eric A Margenau, PHD | |
68 Mattison Rd, Branchville, NJ 07826-4002 | |
(646) 265-4827 | |
(347) 964-5417 |
Full Name | Dr Eric A Margenau |
---|---|
Gender | Male |
Speciality | Psychologist |
Location | 68 Mattison Rd, Branchville, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639400633 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 35SI00166800 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Eric A Margenau, PHD 3777 Independence Ave., Apt. #4h, Bronx, NY 10463-1414 Ph: (646) 265-4827 | Dr Eric A Margenau, PHD 68 Mattison Rd, Branchville, NJ 07826-4002 Ph: (646) 265-4827 |
News Archive
A new study finds reason for caution - a clear emergence of toxicity - in nanomaterial product formulations, but it also provides an early testing technique that could help the industry continue to move forward.
HHS inspector general Daniel Levinson in a report released on Wednesday questioned the legitimacy of a one-year research program conducted by CMS in which the federal government and Medicare beneficiaries paid oncologists a total of about $275 million to report information on chemotherapy side effects that might lead to improved care for cancer patients, the AP/South Florida Sun Sentinel reports.
When it comes to learning languages, adults and children have different strengths. Adults excel at absorbing the vocabulary needed to navigate a grocery store or order food in a restaurant, but children have an uncanny ability to pick up on subtle nuances of language that often elude adults.
Colorectal surgery is a hands-on activity, but in recent years the effectiveness of traditional assessment methods in evaluating surgeons' technical skills has been called into question.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
› Verified 3 days ago
Dr. Lawrence Herbert Lentchner, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 68 Mattison Rd, Branchville, NJ 07826 Phone: 973-946-4388 Fax: 973-948-4388 |